NCT00369070 2018-01-04A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLCAmgenPhase 2 Terminated186 enrolled
NCT00094835 2016-03-24Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)AmgenPhase 1/2 Completed51 enrolled 23 charts
NCT02629848 2015-12-14Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung CancerTakedaPhase 3 Terminated401 enrolled
NCT00460317 2015-09-07MONET1-MOtesanib NSCLC Efficacy and Tolerability StudyAmgenPhase 3 Terminated1,450 enrolled
NCT00324597 2013-09-17AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Unknown18 enrolled